MYP_069145
Basic Information
HPV-31 L1 Cta
Antimicrobial
Antiviral
Antiviral Anti-HPV
Antiviral Antiviral mechanism Viral entry inhibition
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Enzyme modulation Enzyme inhibition Infection inhibition
Standard
13 amino acids
C69H115N25O15
Standard
Sequence
GYRARPKFKAGKR
Physicochemical Analysis
1534.81 Da
11.74
5.76
5.55
0.4428
-1.73
0.48
-0.64
11.49
15.38
0.1538
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
687.72
-6.61
26.0
21.0
52.0
109.0
3.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0277856 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 30.8%, C 69.2% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
RECORD: Rec_0281303 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Infection inhibition
Inhibition of pseudovirions infection
6.515 μM
% inhibition
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
Showing 2 records on this page · Page 2 of 2